Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
NCT06149481 · RECRUITING · Phase 2
ReadTheTrial indexes 1 studies for Metastatic Colorectal Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Metastatic Colorectal Cancer.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
There are 1 clinical trials listed for Metastatic Colorectal Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Metastatic Colorectal Cancer trials are distributed across: Phase 2 (1).